Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.

The kallikrein-kinin system (KKS) is involved in the regulation of blood pressure and in the sodium and water excretion. In humans, the KKS is divided functionally into a plasma KKS (pKKS) generating the biologically active peptide bradykinin and into the tissue (glandular) KKS (tKKS) generating the active peptide kallidin. The objective of this study was to examine the effect of a low-NaCl diet on the concentration of both pKKS and tKKS in plasma and urine in 10 healthy volunteers. After a 4-day low-NaCl diet, the urinary sodium and chloride excretions had decreased from 234 to 21.2 mmol/24 h and from 198 to 14.6 mmol/24 h, respectively. The plasma levels of ANG I, aldosterone, and angiotensin converting enzyme (ACE) significantly increased from 50.4 to 82.8 pg/ml, from 129 to 315 pg/ml, and from 46.4 to 59.8 U/ml, respectively, demonstrating the physiological adjustment to the low-salt diet. In plasma, the levels of bradykinin and plasma kallikrein had significantly decreased from 13.7 to 7.57 pg/ml and 14.4 to 7.13 U/ml, respectively. However, the levels of high-molecular-weight kininogen (HMW kininogen) remain unchanged (101 vs. 112 microg/ml, not significant). Contrary to plasma kallikrein, the plasma levels of tissue kallikrein increased (0.345 vs. 0.500 U/ml; P < 0.01). The plasma kallidin levels, however, did not change (64.7 vs. 68.6 pg/ml, not significant). This can be explained by a simultaneous decrease in the plasma low-molecular-weight kininogen (LMW kininogen) levels (89.9 vs. 44.4 microg/ml; P < 0.05). As in plasma, we find increased urinary concentrations of renal (tissue) kallikrein (23.3 to 42.8 U/24 h; P < 0.05) that contrast with, and are presumably counterbalanced by, urinary LMW kininogen levels (77.0 vs. 51.8 microg/24 h; P < 0.05). Consequently, in urine low-NaCl diet caused no significant change in either bradykinin or kallidin (9.2 vs. 10.8 microg/24 h, and 10.9 vs. 10.3 microg/24 h). It is concluded that the stimulation of the renin-angiotensin system on a low-NaCl diet is associated with a decrease in pKKS (bradykinin and plasma kallikrein) but not in tissue and renal KKS. Although tissue kallikrein is increased, there is no change in kallidin, as LMW kininogen in plasma and urine is decreased. These data suggest a difference in the regulation of pKKS and tKKS by low-salt diet.

[1]  M. Rambausek,et al.  Anaphylactoid reactions during dextran apheresis may occur even in the absence of ACE-inhibitor administration. , 1997, Nephrology, Dialysis and Transplantation.

[2]  O. Carretero,et al.  Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. , 1997, Hypertension.

[3]  J. Damas The Brown Norway rats and the kinin system , 1996, Peptides.

[4]  A. Logan,et al.  Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.

[5]  M. Katori,et al.  Increase in vascular sensitivity to angiotensin II and norepinephrine after four-day infusion of 0.3 M sodium chloride in conscious kininogen-deficient brown Norway Katholiek rats. , 1995, Japanese journal of pharmacology.

[6]  M. Katori,et al.  Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. , 1995, Trends in pharmacological sciences.

[7]  R. Linke,et al.  Strategy of measuring bradykinin and kallidin and their concentration in plasma and urine. , 1995, Analytical biochemistry.

[8]  L. Chao,et al.  Human tissue kallikrein induces hypotension in transgenic mice. , 1994, Hypertension.

[9]  O. Carretero,et al.  Vascular Kallikrein in Deoxycorticosterone Acetate–Salt Hypertensive Rats , 1994, HYPERTENSION.

[10]  H. Siragy Evidence that intrarenal bradykinin plays a role in regulation of renal function. , 1993, The American journal of physiology.

[11]  U. Hilgenfeldt,et al.  Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy. , 1993, The American journal of physiology.

[12]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[13]  N. Toda,et al.  Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries. , 1989, The American journal of physiology.

[14]  W. Müller-Esterl Kininogens, Kinins, and Kinships , 1989, Thrombosis and haemostasis.

[15]  H. Margolius Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. , 1989, Annual review of pharmacology and toxicology.

[16]  R. Vandongen,et al.  Effect of potassium supplementation on blood pressure and vasodilator mechanisms in spontaneously hypertensive rats. , 1988, Clinical science.

[17]  J. Stewart,et al.  Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. , 1986, Hypertension.

[18]  O. Carretero,et al.  Renal kallikrein-kinin system. , 1986, Kidney international.

[19]  J. Granger,et al.  Acute and chronic actions of bradykinin on renal function and arterial pressure. , 1985, The American journal of physiology.

[20]  C. Johnston,et al.  Tissue-specific control of glandular kallikreins. , 1984, American Journal of Physiology.

[21]  A. Harjanne Automated kinetic determination of angiotensin-converting enzyme in serum. , 1984, Clinical Chemistry.

[22]  H. Jacobson,et al.  Interactions of lysyl-bradykinin and antidiuretic hormone in the rabbit cortical collecting tubule. , 1984, The Journal of clinical investigation.

[23]  O. Carretero,et al.  Immunoreactive Glandular Kallikrein in Plasma During Alterations of Urinary Kallikrein Excretion , 1983, HYPERTENSION.

[24]  O. Carretero,et al.  Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. , 1982, The Journal of laboratory and clinical medicine.

[25]  G. Claeson,et al.  Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. , 1979, Advances in experimental medicine and biology.

[26]  M. Katori,et al.  Differential assay method for high molecular weight and low molecular weight kininogens. , 1979, Thrombosis research.

[27]  H. Margolius,et al.  Urinary Kallikrein Excretion in Hypertensive Man: Relationships to Sodium intake and Sodium‐Retaining Steroids , 1974, Circulation research.